ConductScience.org, home

Comparison · NCT00835003-sae

38 Weeks Group vs 39 Weeks Group: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. 38 Weeks Group vs 39 Weeks Group: serious adverse events. Trial comparisons, record NCT00835003-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00835003-sae

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.001570.0002780.00885wilson
Risk in group 20.003130.000860.0114wilson
Risk difference, group 1 minus group 2-0.00156-0.009890.00606newcombe hybrid score
Risk ratio, group 1 over group 20.5020.04565.52log
Odds ratio, group 1 over group 20.5010.04535.54log
Number needed to treat, for one fewer participant with a serious adverse event on 38 Weeks Group than on 39 Weeks Group640from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 138 Weeks GroupElective caesarean section at 38 weeks and 3 days of gestation~Elective caesarean section: Procedure performed at 38 weeks and 3 days of gestation (+/- 2 days)1636EG000
Group 239 Weeks GroupElective caesarean section at 39 weeks and 3 days of gestation~Elective caesarean section: Procedure performed at 39 weeks and 3 days of gestation (+/- 2 days)2638EG001

Harm

What it counts
Total, serious adverse events
Time frame
30 days

Source ClinicalTrials.gov

Trial

Title
Timing of Planned Caesarean Section and Morbidity of the Newborn
NCT number
NCT00835003
Phases
NA
Conditions
Respiratory Disorders, Intensive Care, Neonatal
Interventions
Elective caesarean section, Elective caesarean section
Lead sponsor
Aarhus University Hospital
Results first posted
2014-07-03

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00835003-sae